A randomized, controlled trial on fenofibrate in primary biliary cholangitis patients with incomplete response to ursodeoxycholic acid.

Chunlei LiKunyu ZhengYiran ChenChengmei He Suying LiuYunjiao YangMeng Tao LiXiaofeng ZengLi WangFengchun Zhang

Published in: Therapeutic advances in chronic disease (2022)

Addition of fenofibrate can improve biochemical indexes of PBC patients who had an incomplete response to UDCA. Reversible elevation of serum creatine and transaminases is observed in some patients.The trial was registered in the Chinese Clinical Trial Registry (ChiCTR) as ChiCTR1800020160 (protocol available online: http://www.chictr.org.cn/showproj.aspx?proj=32443).

Keyphrases

clinical trial
end stage renal disease
newly diagnosed
study protocol
ejection fraction
randomized controlled trial
phase ii
phase iii
prognostic factors
peritoneal dialysis
social media
healthcare
lymph node metastasis
ulcerative colitis
patient reported